PROCEEDINGS ABSTRACT |
open access
Design, synthesis, characterization, and in silico assessment of novel 1,3,4-thiadiazole–urea derivatives as inhibitors of the vascular endothelial growth factor receptor 2
Noora A. Al-Jubouri*, Shaker A. Abdul Hussein, Hussam W. Al-Humadi
College of Pharmacy, University of Babylon, Hillah, Iraq (NAA, HWA) ▪ Department of Pharmaceutical Chemistry, College of Pharmacy, University of Babylon, Hillah, Iraq (SAAH)
*corresponding author (pha155.noora.ali@student.uobabylon.edu.iq)
Received: 30 March 2026; Revised: 26 May 2026; Accepted: 17 June 2026; Published: 23 June 2026
DOI: 10.5281/zenodo.20808354
Full-text proceedings abstract: PDF
Keywords: ADME; cancer; molecular docking; 1,3,4-thiadiazole; VEGFR-2
Al-Jubouri N. A., Abdul Hussein S. A., Al-Humadi H. W.: Design, synthesis, characterization, and in silico assessment of novel 1,3,4-thiadiazole–urea derivatives as inhibitors of the vascular endothelial growth factor receptor 2. Colloq. Erud. 1: 31–32 (2026).
https://doi.org/10.5281/zenodo.20808354
PREVIOUS PROCEEDINGS ABSTRACT ▪ VOLUME 1 (2026) ▪ NEXT PROCEEDINGS ABSTRACT